Cited by 1,732Genomics and Chromatin DynamicsProtein Degradation and InhibitorsProtein Structure and Dynamics

The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.

Structure and ligand of a histone acetyltransferase bromodomain

Dhalluin, Christophe, Carlson, Justin E., Zeng, Lei, He, Cheng, Aggarwal, Aneel K., Zhou, Ming-Ming, Zhou, Ming-Ming·1999·Nature

DOI 10.1038/20974

Open this paper in CoChat — free account

Abstract

Histone acetylation is important in chromatin remodelling and gene activation. Nearly all known histone-acetyltransferase (HAT)-associated transcriptional co-activators contain bromodomains, which are approximately 110-amino-acid modules found in many chromatin-associated proteins. Despite the wide occurrence of these bromodomains, their three-dimensional structure and binding partners remain unknown. Here we report the solution structure of the bromodomain of the HAT co-activator P/CAF (p300/CBP-associated factor). The structure reveals an unusual left-handed up-and-down four-helix bundle. In addition, we show by a combination of structural and site-directed mutagenesis studies that bromodomains can interact specifically with acetylated lysine, making them the first known protein modules to do so. The nature of the recognition of acetyl-lysine by the P/CAF bromodomain is similar to that of acetyl-CoA by histone acetyltransferase. Thus, the bromodomain is functionally linked to the HAT activity of co-activators in the regulation of gene transcription.

Integrity signals

Registry

Crossref · 10.1038/20974

Cites

30 of 30 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

AQUA and PROCHECK-NMR: Programs for checking the quality of protein structures solved by NMR
Laskowski, R., Rullmann, J. A., MacArthur, M., Kaptein, R., & Thornton, J. (1996) · Journal of Biomolecular NMR · doi:10.1007/bf00228148 · Cited by 5,502
X-PLOR Version 3.1: A System for X-ray Crystallography and NMR
Brünger, A. T. (1992) · Medical Entomology and Zoology · Cited by 3,424
The Anatomy and Taxonomy of Protein Structure
Richardson, J. S. (1981) · Advances in protein chemistry · doi:10.1016/s0065-3233(08)60520-3 · Cited by 3,378
NMR View: A computer program for the visualization and analysis of NMR data
Johnson, B. A., & Blevins, R. A. (1994) · Journal of Biomolecular NMR · doi:10.1007/bf00404272 · Cited by 3,093
The Transcriptional Coactivators p300 and CBP Are Histone Acetyltransferases
Ogryzko, V. V., Schiltz, R. L., Russanova, V., Howard, B. H., & Nakatani, Y. (1996) · Cell · doi:10.1016/s0092-8674(00)82001-2 · Cited by 2,952
Histone acetylation in chromatin structure and transcription
Grunstein, M. (1997) · Nature · doi:10.1038/38664 · Cited by 2,884
Protein modules and signalling networks
Pawson, T. (1995) · Nature · doi:10.1038/373573a0 · Cited by 2,420
The CBP co-activator is a histone acetyltransferase
Bannister, A. J., & Kouzarides, T. (1996) · Nature · doi:10.1038/384641a0 · Cited by 1,828
Tetrahymena Histone Acetyltransferase A: A Homolog to Yeast Gcn5p Linking Histone Acetylation to Gene Activation
Brownell, J. E., Zhou, J., Ranalli, T. A., Kobayashi, R., Edmondson, D. G., Dent, S., & Allis, C. D. (1996) · Cell · doi:10.1016/s0092-8674(00)81063-6 · Cited by 1,636
A p300/CBP-associated factor that competes with the adenoviral oncoprotein E1A
Yang, X., Ogryzko, V. V., Nishikawa, J., Howard, B. H., & Nakatani, Y. (1996) · Nature · doi:10.1038/382319a0 · Cited by 1,497

Flagged first, then by citations

Show all 30 references

Research works printed but not linked: 1

Nicholls, A., Bharadwj, R. & Honig, B. GRASP: Graphical representation and analysis of surface properties. Biophys. J. 64, 166–170 (1993).

Sorted by citations

Items 701–800 of 1,001

BET inhibitors as novel therapeutic agents in breast cancer
Ocaña, A., Nieto‐Jiménez, C., & Pandiella, A. (2017) · Oncotarget · doi:10.18632/oncotarget.19744 · Cited by 48
ATAD2 in cancer: a pharmacologically challenging but tractable target
Hussain, M., Zhou, Y., Song, Y., Hameed, H. M. A., Jiang, H., Tu, Y., & Zhang, J. (2017) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2018.1406921 · Cited by 48
PBRM1 bromodomains variably influence nucleosome interactions and cellular function
Slaughter, M. J., Shanle, E. K., McFadden, A. W., Hollis, E. S., Suttle, L. E., Strahl, B. D., & Davis, I. J. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.ra118.003381 · Cited by 48
Unspinning chromatin: Revealing the dynamic nucleosome landscape by NMR
van Emmerik, C. L., & van Ingen, H. (2019) · Progress in Nuclear Magnetic Resonance Spectroscopy · doi:10.1016/j.pnmrs.2019.01.002 · Cited by 52
Validation of the epigenetic reader bromodomain-containing protein 4 (BRD4) as a therapeutic target for treatment of airway remodeling
Brasier, A. R., & Zhou, J. (2019) · Drug Discovery Today · doi:10.1016/j.drudis.2019.11.002 · Cited by 48
Distinct roles for H4 and H2A.Z acetylation in RNA transcription in African trypanosomes
Kraus, A. J., Vanselow, J. T., Lamer, S., Brink, B. G., Schlösser, A., & Siegel, T. N. (2020) · Nature Communications · doi:10.1038/s41467-020-15274-0 · Cited by 48
Displacement of Histones at Promoters of Saccharomyces cerevisiae Heat Shock Genes Is Differentially Associated with Histone H3 Acetylation
Erkina, T. Y., & Erkine, A. M. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.00666-06 · Cited by 47
XP-524 is a dual-BET/EP300 inhibitor that represses oncogenic KRAS and potentiates immune checkpoint inhibition in pancreatic cancer
Principe, D. R., Xiong, R., Li, Y., Pham, T. D., Kamath, S. D., Dubrovskyi, O., Ratia, K. M., Huang, F., Zhao, J., Shen, Z., et al. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2116764119 · Cited by 47
Small Molecule Bromodomain Inhibitors
Chung, C. (2012) · Progress in medicinal chemistry · doi:10.1016/b978-0-12-396493-9.00001-7 · Cited by 49
Assays for the Determination of Structure and Dynamics of the Interaction of the Chromodomain with Histone Peptides
Jacobs, S. A., Fischle, W., & Khorasanizadeh, S. (2003) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(03)76009-1 · Cited by 47
Chemical modulators for epigenome reader domains as emerging epigenetic therapies for cancer and inflammation
Zaware, N., & Zhou, M. (2017) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2017.06.012 · Cited by 49
Self-citation
Hippo Pathway and YAP Signaling Alterations in Squamous Cancer of the Head and Neck
Santos-de-Frutos, K., Segrelles, C., & Lorz, C. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8122131 · Cited by 49
What do the structures of GCN5-containing complexes teach us about their function?
Helmlinger, D., Pápai, G., Devys, D., & Tora, L. (2020) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2020.194614 · Cited by 49
Epigenetic Effects of Benzene in Hematologic Neoplasms: The Altered Gene Expression
Spatari, G., Allegra, A., Carrieri, M., Pioggia, G., & Gangemi, S. (2021) · Cancers · doi:10.3390/cancers13102392 · Cited by 53
The Swi2/Snf2 Bromodomain Is Important for the Full Binding and Remodeling Activity of the SWI/SNF Complex on H3‐ and H4‐acetylated Nucleosomes
Awad, S. M., & Hassan, A. H. (2008) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1414.038 · Cited by 47
Reproductive Cycle Regulation of Nuclear Import, Euchromatic Localization, and Association with Components of Pol II Mediator of a Mammalian Double-Bromodomain Protein
Crowley, T. E., Kaine, E. M., Yoshida, M., Nandi, A. A., & Wolgemuth, D. J. (2002) · Molecular Endocrinology · doi:10.1210/me.2001-0353 · Cited by 48
Recent progress and structural analyses of domain‐selective BET inhibitors
Divakaran, A., Harki, D. A., & Pomerantz, W. C. K. (2023) · Medicinal Research Reviews · doi:10.1002/med.21942 · Cited by 48
Epigenetics in the modern era of crop improvements
Xue, Y., Cao, X., Chen, X., Deng, X. M., Deng, X. W., Ding, Y., Dong, A., Duan, C., Fang, X., Gong, L., et al. (2025) · Science China Life Sciences · doi:10.1007/s11427-024-2784-3 · Cited by 52
Self-citation
Writers, Readers, and Erasers of Epigenetic Marks
Nicholson, T. B., Veland, N., & Chen, T. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-800206-3.00003-3 · Cited by 49
Biology of Polycomb and Trithorax Group Proteins
Breiling, A., Sessa, L., & Orlando, V. (2007) · International review of cytology · doi:10.1016/s0074-7696(07)58002-2 · Cited by 46
A Double-Bromodomain Protein, FSH-S, Activates the Homeotic Gene Ultrabithorax through a Critical Promoter-Proximal Region
Chang, Y.-L., King, B. O., Lin, S., Kennison, J. A., & Huang, D.-H. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.00692-07 · Cited by 46
Strategies for large-scale analysis of non-histone protein methylation by LC-MS/MS
Wang, Q., Wang, K., & Ye, M. (2017) · The Analyst · doi:10.1039/c7an00954b · Cited by 46
Structural Mechanism of the Oxygenase JMJD6 Recognition by the Extraterminal (ET) Domain of BRD4
Konuma, T., Yu, D., Zhao, C., Ju, Y., Sharma, R., Ren, C., Zhang, Q., Zhou, M., & Zeng, L. (2017) · Scientific Reports · doi:10.1038/s41598-017-16588-8 · Cited by 45
Self-citation
Therapeutic targeting of p300/CBP HAT domain for the treatment of NUT midline carcinoma
Zhang, X., Zegar, T., Lucas, A., Morrison-Smith, C. D., Knox, T. M., French, C. A., Knapp, S., Müller, S., & Siveke, J. T. (2020) · Oncogene · doi:10.1038/s41388-020-1301-9 · Cited by 46
Deficient histone acetylation and excessive deacetylase activity as epigenomic marks of prostate cancer cells
Chiao (2009) · International Journal of Oncology · doi:10.3892/ijo_00000459 · Cited by 46
Structural implications for K5/K12‐di‐acetylated histone H4 recognition by the second bromodomain of BRD2
Umehara, T., Nakamura, Y., Wakamori, M., Ozato, K., Yokoyama, S., & Padmanabhan, B. (2010) · FEBS Letters · doi:10.1016/j.febslet.2010.08.013 · Cited by 45
Epigenetic changes in cancer by Raman imaging, fluorescence imaging, AFM and scanning near-field optical microscopy (SNOM). Acetylation in normal and human cancer breast cells MCF10A, MCF7 and MDA-MB-231
Abramczyk, H., Surmacki, J. M., Kopeć, M., Olejnik, A. K., Kaufman‐Szymczyk, A., & Fabianowska‐Majewska, K. (2016) · The Analyst · doi:10.1039/c6an00859c · Cited by 44
Epigenetics of Bladder Cancer: Where Biomarkers and Therapeutic Targets Meet
Martínez, V. G., Munera-Maravilla, E., Bernardini, A., Rubio, C., Suárez-Cabrera, C., Segovia, C., Lodewijk, I., Dueñas, M., Martínez‐Fernández, M., & Paramio, J. M. (2019) · Frontiers in Genetics · doi:10.3389/fgene.2019.01125 · Cited by 45
Targeting BRD9 for Cancer Treatment: A New Strategy
Zhu, X., Liao, Y., & Tang, L. (2020) · OncoTargets and Therapy · doi:10.2147/ott.s286867 · Cited by 45
YAP1 maintains active chromatin state in head and neck squamous cell carcinomas that promotes tumorigenesis through cooperation with BRD4
Chen, N., Golczer, G., Ghose, S., Lin, B., Langenbucher, A., Webb, J., Bhanot, H., Abt, N. B., Lin, D. T., Varvares, M. A., et al. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.110970 · Cited by 45
Molecular cloning and characterization of an SRCAP chromatin remodeling homologue in Toxoplasma gondii
Sullivan, W. J., Monroy, M. A., Bohne, W., Nallani, K. C., Chrivia, J. C., Yaciuk, P., Smith, C. K., & Queener, S. F. (2003) · Parasitology Research · doi:10.1007/s00436-002-0814-1 · Cited by 44
Unbiased proteomic screen for binding proteins to modified lysines on histone H3
Chan, D. W., Wang, Y., Wu, M., Wong, J., Qin, J., & Zhao, Y. (2009) · PROTEOMICS · doi:10.1002/pmic.200800600 · Cited by 45
Progress in the Discovery of Small-Molecule Inhibitors of Bromodomain–Histone Interactions
Chung, C., & Witherington, J. J. (2011) · SLAS DISCOVERY · doi:10.1177/1087057111421372 · Cited by 45
Pharmacological targeting of BET proteins inhibits renal fibroblast activation and alleviates renal fibrosis
Xiong, C., Masucci, M. V., Zhou, X., Liu, N., Zang, X., Tolbert, E. M., Zhao, T. C., & Zhuang, S. (2016) · Oncotarget · doi:10.18632/oncotarget.12498 · Cited by 44
Selective inhibition mechanism of RVX-208 to the second bromodomain of bromo and extraterminal proteins: insight from microsecond molecular dynamics simulations
Wang, Q., Li, Y., Xu, J., Wang, Y., Leung, E. L., Liu, L., & Yao, X. (2017) · Scientific Reports · doi:10.1038/s41598-017-08909-8 · Cited by 44
The Contribution and Therapeutic Potential of Epigenetic Modifications in Alzheimer’s Disease
Wood, I. C. (2018) · Frontiers in Neuroscience · doi:10.3389/fnins.2018.00649 · Cited by 44
Targeting Hippo coactivator YAP1 through BET bromodomain inhibition in esophageal adenocarcinoma
Song, S., Li, Y., Xu, Y., Ma, L., Pizzi, M. P., Jin, J., Scott, A. W., Huo, L., Wang, Y., Lee, J. H., et al. (2020) · Molecular Oncology · doi:10.1002/1878-0261.12667 · Cited by 44
Epigenetics of Most Aggressive Solid Tumors: Pathways, Targets and Treatments
Martínez‐Useros, J., Martin-Galan, M., Florez-Cespedes, M., & García‐Foncillas, J. (2021) · Cancers · doi:10.3390/cancers13133209 · Cited by 46
The CBP Bromodomain and Nucleosome Targeting Are Required for Zta-Directed Nucleosome Acetylation and Transcription Activation
Deng, Z., Chen, C., Chamberlin, M., Lu, F. Y., Blobel, G. A., Speicher, D. W., Cirillo, L. A., Zaret, K. S., & Lieberman, P. M. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.8.2633-2644.2003 · Cited by 44
Recognition of CpG Island Chromatin by KDM2A Requires Direct and Specific Interaction with Linker DNA
Zhou, J., Blackledge, N. P., Farcas, A. M., & Klose, R. J. (2011) · Molecular and Cellular Biology · doi:10.1128/mcb.06332-11 · Cited by 45
Spt-Ada-Gcn5-Acetyltransferase (SAGA) Complex in Plants: Genome Wide Identification, Evolutionary Conservation and Functional Determination
Srivastava, R., Mohan, K., Pandey, B., Singh, S. P., & Sawant, S. V. (2015) · PLoS ONE · doi:10.1371/journal.pone.0134709 · Cited by 47
Sequence and expression analyses of KIX domain proteins suggest their importance in seed development and determination of seed size in rice, and genome stability in Arabidopsis
Thakur, J. K., Agarwal, P., Parida, S. K., Bajaj, D., & Pasrija, R. (2013) · Molecular Genetics and Genomics · doi:10.1007/s00438-013-0753-9 · Cited by 44
Inhibition of bromodomain-containing protein 9 for the prevention of epigenetically-defined drug resistance
Crawford, T. D., Vartanian, S., Côté, A., Bellon, S. F., Duplessis, M., Flynn, E. M., Hewitt, M. C., Huang, H.-R., Kiefer, J. R., Murray, J. M., et al. (2017) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2017.05.063 · Cited by 43
The kinetochore module Okp1CENP‐Q/Ame1CENP‐U is a reader for N‐terminal modifications on the centromeric histone Cse4CENP‐A
Anedchenko, E. A., Samel‐Pommerencke, A., Nguyen, T. M. T., Shahnejat‐Bushehri, S., Pöpsel, J., Lauster, D. C., Herrmann, A., Rappsilber, J., Cuomo, A., Bonaldi, T., et al. (2018) · The EMBO Journal · doi:10.15252/embj.201898991 · Cited by 43
Structure-Based Approach toward Identification of Inhibitory Fragments for Eleven-Nineteen-Leukemia Protein (ENL)
Heidenreich, D. J., Moustakim, M., Schmidt, J., Merk, D., Brennan, P. E., Fedorov, O., Chaikuad, A., & Knapp, S. (2018) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.8b01457 · Cited by 43
BET Inhibition Improves NASH and Liver Fibrosis
Middleton, S. A., Rajpal, N., Cutler, L., Mander, P. K., Rioja, I., Prinjha, R. K., Rajpal, D. K., Agarwal, P., & Kumar, V. (2018) · Scientific Reports · doi:10.1038/s41598-018-35653-4 · Cited by 43
Pharmacological Targeting of BET Bromodomain Proteins in Acute Myeloid Leukemia and Malignant Lymphomas: From Molecular Characterization to Clinical Applications
Reyes-Garau, D., Ribeiro, M. L., & Roué, G. (2019) · Cancers · doi:10.3390/cancers11101483 · Cited by 45
The Role of Histone Modifications in Epigenetic Transitions During Normal and Perturbed Development
Kubicek, S., Schotta, G., Lachner, M., SENGUPTA, R., Kohlmaier, A., Perez-Burgos, L., Linderson, Y., Martens, J. H. A., O’Sullivan, R. J., Fodor, B. D., et al. (2006) · Springer eBooks · doi:10.1007/3-540-37633-x_1 · Cited by 43
Abundance of the RSC nucleosome‐remodeling complex is important for the cells to tolerate DNA damage in Saccharomyces cerevisiae
Koyama, H., Itoh, M., Miyahara, K., & Tsuchiya, E. (2002) · FEBS Letters · doi:10.1016/s0014-5793(02)03504-4 · Cited by 43
TAF250 is required for multiple developmental events in Drosophila
Wassarman, D. A., Aoyagi, N., Pile, L. A., & Schlag, E. M. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.3.1154 · Cited by 43
Acetylation in hormone signaling and the cell cycle
Fu, M., Wang, C., Wang, J., Zafonte, B. T., Lisanti, M. P., & Pestell, R. G. (2002) · Cytokine & Growth Factor Reviews · doi:10.1016/s1359-6101(02)00003-5 · Cited by 43
Acetylation of Yeast Histone H4 Lysine 16: A Switch for Protein Interactions in Heterochromatin and EuchromatinPreprint
Millar, C. B., Kurdistani, S. K., & Grunstein, M. R. (2004) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.2004.69.193 · Cited by 43
SWI/SNF Chromatin Remodelers: Structural, Functional and Mechanistic Implications
Singh, A., Modak, S. B., Chaturvedi, M. M., & Purohit, J. S. (2023) · Cell Biochemistry and Biophysics · doi:10.1007/s12013-023-01140-5 · Cited by 42
Degraders in epigenetic therapy: PROTACs and beyond
Dai, X., Ji, S., Fu, M., Liu, G.-Z., Liu, H., Wang, S., Shen, L., Wang, N., Herdewijn, P. A., Zheng, Y., et al. (2024) · Theranostics · doi:10.7150/thno.92526 · Cited by 45
Epigenetic regulation of bone cells
Park‐Min, K. H. (2016) · Connective Tissue Research · doi:10.1080/03008207.2016.1177037 · Cited by 42
CRISPR-Mediated Epigenome Editing.
Enríquez, P. (2016) · Europe PMC (PubMed Central) · Cited by 41
Development of a new diagnostic Raman method for monitoring epigenetic modifications in the cancer cells of human breast tissue
Brożek-Płuska, B., Kopeć, M., & Abramczyk, H. (2016) · Analytical Methods · doi:10.1039/c6ay02559e · Cited by 42
Dynamic regulation of lysine acetylation: the balance between acetyltransferase and deacetylase activities
Hyndman, K. A., & Knepper, M. A. (2017) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00313.2017 · Cited by 42
Targeting Histone Acetylation
Benton, C. B., Fiskus, W. C., & Bhalla, K. N. (2017) · The Cancer Journal · doi:10.1097/ppo.0000000000000284 · Cited by 42
Biomimetic Artificial Epigenetic Code for Targeted Acetylation of Histones
Taniguchi, J., Feng, Y., Pandian, G. N., Hashiya, F., Hidaka, T., Hashiya, K., Park, S., Bando, T., Ito, S., & Sugiyama, H. (2018) · Journal of the American Chemical Society · doi:10.1021/jacs.8b01518 · Cited by 42
Disease-related potential of mutations in transcriptional cofactors CREB-binding protein and p300 in leukemias
Shigeno, K., Yoshida, H., Pan, L., Luo, J. M., Fujisawa, S., Naito, K., Nakamura, S., Shinjo, K., Takeshita, A., Ohno, R., et al. (2003) · Cancer Letters · doi:10.1016/s0304-3835(03)00442-7 · Cited by 41
Regulation of muscle regulatory factors by DNA-binding, interacting proteins, and post-transcriptional modifications
Puri, P., & Sartorelli, V. (2000) · Journal of Cellular Physiology · doi:10.1002/1097-4652(200011)185:2 · Cited by 299
A Novel Protein with Similarities to Rb Binding Protein 2 Compensates for Loss of Chk1 Function and Affects Histone Modification in Fission Yeast
Ahmed, S., Palermo, C., Wan, S., & Walworth, N. C. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.9.3660-3669.2004 · Cited by 42
Exposure time versus cytotoxicity for anticancer agents
Evans, D. M., Fang, J., Silvers, T. R., Delosh, R., Laudeman, J. A., Ogle, C., Reinhart, R. A., Selby, M. J. P., Bowles, L., Connelly, J., et al. (2019) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-019-03863-w · Cited by 43
Epigenetik – ein Epizentrum der Genregulation: Histone und histonmodifizierende Enzyme
Biel, M., Wascholowski, V., & Giannis, A. (2005) · Angewandte Chemie · doi:10.1002/ange.200461346 · Cited by 42
Bromodomain Proteins in HIV Infection
Boehm, D., Conrad, R., & Ott, M. (2013) · Viruses · doi:10.3390/v5061571 · Cited by 42
Overexpression of bromodomain factor 3 in Trypanosoma cruzi ( Tc BDF 3) affects differentiation of the parasite and protects it against bromodomain inhibitors
Alonso, V. L., Ritagliati, C., Cribb, P., Cricco, J. A., & Serra, E. C. (2016) · FEBS Journal · doi:10.1111/febs.13719 · Cited by 41
Hdac4 Interactions in Huntington's Disease Viewed Through the Prism of Multiomics
Federspiel, J. D., Greco, T. M., Lum, K. K., & Cristea, I. M. (2019) · Molecular & Cellular Proteomics · doi:10.1074/mcp.ra118.001253 · Cited by 41
Promoter-specific changes in initiation, elongation, and homeostasis of histone H3 acetylation during CBP/p300 inhibition
Hsu, E., Zemke, N. R., & Berk, A. J. (2021) · eLife · doi:10.7554/elife.63512 · Cited by 41
Pharmacological targeting of lysine acetyltransferases in human disease: a progress report
Heery, D. M., & Fischer, P. M. (2006) · Drug Discovery Today · doi:10.1016/j.drudis.2006.11.012 · Cited by 41
Dynamic Histone Acetylation/Deacetylation with Progesterone Receptor-Mediated Transcription
Aoyagi, S., & Archer, T. (2007) · Molecular Endocrinology · doi:10.1210/me.2006-0244 · Cited by 41
Epigenetic modulators provide a path to understanding disease and therapeutic opportunityPreprint
Honer, M. A., Ferman, B. I., Gray, Z. H., Bondarenko, E. A., & Whetstine, J. R. (2024) · Genes & Development · doi:10.1101/gad.351444.123 · Cited by 44
The Emerging Roles of ATP-Dependent Chromatin Remodeling Enzymes in Nucleotide Excision Repair
Czaja, W., Mao, P., & Smerdon, M. J. (2012) · International Journal of Molecular Sciences · doi:10.3390/ijms130911954 · Cited by 40
Post-translational Lysine Ac(et)ylation in Bacteria: A Biochemical, Structural, and Synthetic Biological Perspective
Lammers, M. (2021) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.757179 · Cited by 41
Brd2 Gene Disruption Causes “Metabolically Healthy” Obesity
Wang, F., Deeney, J. T., & Denis, G. V. (2013) · Vitamins and hormones · doi:10.1016/b978-0-12-407766-9.00003-1 · Cited by 41
Prognostic relevance of BRD 7 expression in colorectal carcinoma
Wu, W., Hu, K., Chen, D., Zeng, Z.-L., Luo, H., Wang, F., Wang, D., Wang, Z., He, F., & Xu, R. (2012) · European Journal of Clinical Investigation · doi:10.1111/eci.12024 · Cited by 40
DNA-binding properties of the recombinant high-mobility-group-like AT-hook-containing region from human BRG1 protein
Singh, M., D’Silva, L., & Holak, T. A. (2006) · Biological Chemistry · doi:10.1515/bc.2006.184 · Cited by 40
TRIM66 reads unmodified H3R2K4 and H3K56ac to respond to DNA damage in embryonic stem cells
Chen, J., Wang, Z., Guo, X., Li, F., Wei, Q., Chen, X., Gong, D., Xu, Y., Chen, W., Liu, Y., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-12126-4 · Cited by 41
A Bromodomain-Containing Protein 4 (BRD4) Inhibitor Suppresses Angiogenesis by Regulating AP-1 Expression
Zhou, Z., Li, X., Liu, Z., Huang, L., Yao, Y., Li, L., Chen, J., Zhang, R., Zhou, J., Wang, L., et al. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.01043 · Cited by 40
Lysine acetylation: enzymes, bromodomains and links to different diseases
You, L., Nie, J., Sun, W., Zheng, Z., & Yang, X. (2012) · Essays in Biochemistry · doi:10.1042/bse0520001 · Cited by 42
Cloning and characterization of hELD/OSA1, a novel BRG1 interacting protein
Hurlstone, A. F. L., Olave, I. A., Barker, N., van Noort, M., & Clevers, H. C. (2002) · Biochemical Journal · doi:10.1042/bj3640255 · Cited by 40
The Nonessential H2A N-Terminal Tail Can Function as an Essential Charge Patch on the H2A.Z Variant N-Terminal Tail
Ren, Q., & Gorovsky, M. A. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.8.2778-2789.2003 · Cited by 39
The proliferation marker pKi‐67 organizes the nucleolus during the cell cycle depending on Ran and cyclin B
Schmidt, M. H. H., Broll, R., Bruch, H., Bogler, O., & Duchrow, M. (2003) · Journal of Pathology · doi:10.1002/path.1221 · Cited by 43
Cloning and analysis of a Toxoplasma gondii histone acetyltransferase: a novel chromatin remodelling factor in Apicomplexan parasites
Hettmann, C., & Soldati‐Favre, D. (1999) · Nucleic Acids Research · doi:10.1093/nar/27.22.4344 · Cited by 40
Garcinol, an Acetyltransferase Inhibitor, Suppresses Proliferation of Breast Cancer Cell Line MCF-7 Promoted by 17β-Estradiol
Ye, X., Yuan, L., Zhang, L., Zhao, J., Zhang, C., & Deng, H. (2014) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2014.15.12.5001 · Cited by 39
Chemical Protein Degradation Approach and its Application to Epigenetic Targets
Itoh, Y. (2018) · The Chemical Record · doi:10.1002/tcr.201800032 · Cited by 41
CREBBP/EP300 Bromodomain Inhibition Affects the Proliferation of AR-Positive Breast Cancer Cell Lines
García-Carpizo, V., Ruiz‐Llorente, S., Sarmentero, J., González‐Corpas, A., & Barrero, M. J. (2019) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-18-0719 · Cited by 39
Novel Pyrrolopyridone Bromodomain and Extra-Terminal Motif (BET) Inhibitors Effective in Endocrine-Resistant ER+ Breast Cancer with Acquired Resistance to Fulvestrant and Palbociclib
Li, Y., Zhao, J., Gutgesell, L. M., Shen, Z., Ratia, K. M., Dye, K., Dubrovskyi, O., Zhao, H., Huang, F., Tonetti, D. A., et al. (2020) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.0c00456 · Cited by 40
Targeting non-canonical activation of GLI1 by the SOX2-BRD4 transcriptional complex improves the efficacy of HEDGEHOG pathway inhibition in melanoma
Pietrobono, S., Gaudio, E., Gagliardi, S., Zitani, M., Carrassa, L., Migliorini, F., Petricci, E., Manetti, F., Makukhin, N., Bond, A. G., et al. (2021) · Oncogene · doi:10.1038/s41388-021-01783-9 · Cited by 38
Discovery of novel 4-phenylquinazoline-based BRD4 inhibitors for cardiac fibrosis
He, Z., Jiao, H., An, Q., Zhang, X., Dan, Z., Xu, J., Liu, H., Ma, L., & Zhao, W. H. (2021) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2021.07.018 · Cited by 42
Transcriptional Regulation of Dentin Matrix Protein 1 by JunB and p300 during Osteoblast Differentiation
Narayanan, K., Srinivas, R., Peterson, M. C., Ramachandran, A., Hao, J. J., Thimmapaya, B., Scherer, P. E., & George, A. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m403511200 · Cited by 43
Biochemical Profiling of Histone Binding Selectivity of the Yeast Bromodomain Family
Zhang, Q., Chakravarty, S., Ghersi, D., Zeng, L., Plotnikov, A. N., Sánchez, R., & Zhou, M. (2010) · PLoS ONE · doi:10.1371/journal.pone.0008903 · Cited by 39
Self-citation
HBXAP, a Novel PHD-Finger Protein, Possesses Transcription Repression Activity
Shamay, M., Barak, O. G., & Shaul, Y. (2002) · Genomics · doi:10.1006/geno.2002.6717 · Cited by 39
Bromodomains in living cells participate in deciphering the histone code
Loyola, A., & Almouzni, G. (2004) · Trends in Cell Biology · doi:10.1016/j.tcb.2004.04.005 · Cited by 39
Dual-target Inhibitors Based on BRD4: Novel Therapeutic Approaches for Cancer
Zhang, S., Chen, Y., Tian, C., He, Y., Tian, Z., Wan, Y., & Liu, T. (2020) · Current Medicinal Chemistry · doi:10.2174/0929867327666200610174453 · Cited by 37
Targeting bromodomain-containing proteins: research advances of drug discovery
Pan, Z., Zhao, Y., Wang, X., Xie, X., Liu, M., Zhang, K., Wang, L., Bai, D., Foster, L. J., Shu, R., et al. (2023) · Molecular Biomedicine · doi:10.1186/s43556-023-00127-1 · Cited by 43
Does bromodomain flexibility influence histone recognition?
Steiner, S., Magno, A., Danzhi Huang, A., & Caflisch, A. (2013) · FEBS Letters · doi:10.1016/j.febslet.2013.05.032 · Cited by 40
NUT carcinoma of the thorax: Case report and review of the literature
Harms, A., Herpel, E., Pfarr, N., Penzel, R., Heußel, C. P., Herth, F. J. F., Dienemann, H., Weichert, W., & Warth, A. (2015) · Lung Cancer · doi:10.1016/j.lungcan.2015.10.001 · Cited by 38
BRD4 regulates fructose-inducible lipid accumulation-related genes in the mouse liver
Aki, Y., Honma, K., Mochizuki, K., & Goda, T. (2016) · Metabolism · doi:10.1016/j.metabol.2016.07.001 · Cited by 38
Early butyrate induced acetylation of histone H4 is proteoform specific and linked to methylation state
Wang, T., Holt, M. V., & Young, N. L. (2018) · Epigenetics · doi:10.1080/15592294.2018.1475979 · Cited by 38

Authors: Dhalluin, C., Carlson, J. E., Zeng, L., He, C., Aggarwal, A. K., Zhou, M.-M., & Zhou, M.-M.
Affiliations: Icahn School of Medicine at Mount Sinai (US)
ORCID: Zeng, Lei
Aggarwal, Aneel K.
Venue: Nature
Publisher: Springer Science and Business Media LLC
Published: 1999-06
Volume: 399
Issue: 6735
Pages: 491-496
ISSN: 0028-0836 (ISSN-L)
1476-4687
DOI: 10.1038/20974
OpenAlex: W1625510017
Cited by: 1,732
References: 30
Citations by year: 2026: 50 · 2025: 58 · 2024: 68 · 2023: 75 · 2022: 64 · 2021: 74 · 2020: 75 · 2019: 80 · 2018: 85 · 2017: 84 · 2016: 100 · 2015: 66 · 2014: 67 · 2013: 63 · 2012: 50
FWCI: 25.15
Type: journal article
Language: en
Open access: closed
Licence: www.springer.com/tdm (tdm)
Locations: Nature (publishedVersion)
PubMed (publishedVersion)
RePEc: Research Papers in Economics (submittedVersion)
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Degradation and Inhibitors
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Structure and Dynamics
Keywords: bromodomain, histone acetyltransferase, PCAF, protein structure, four-helix bundle, histone acetylation, transcriptional regulation, acetyl-CoA binding
MeSH terms: p300-CBP-Associated Factor, Acetyltransferases, Amino Acid Sequence, Escherichia coli, Ligands, Lysine, Models, Molecular, Molecular Sequence Data, Protein Binding, Protein Conformation, Recombinant Proteins, Transcription Factors, Mutagenesis, Site-Directed, Sequence Homology, Amino Acid, Bromine Compounds, Crystallography, X-Ray, Cell Cycle Proteins, Saccharomyces cerevisiae Proteins, p300-CBP Transcription Factors, Histone Acetyltransferases

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Structure and ligand of a histone acetyltransferase bromodomain

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks